Related Experiment Videos
Management of cutaneous T-cell lymphoma: The future is here
1Division of Dermatology, University of Wisconsin, Madison, USA.
Journal of the American Academy of Dermatology
|July 21, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?
The British journal of dermatology·2014
Polo-like kinase 1 (Plk1) in cutaneous T-cell lymphoma.
The British journal of dermatology·2010
Genomic instability in radial growth phase melanoma cell lines after ultraviolet irradiation.
Journal of clinical pathology·2005
p53-related pathways and the molecular pathogenesis of melanoma.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2003
Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States.
Journal of cutaneous pathology·2001
HPV-Associated Cutaneous Malignancy in Solid Organ Transplant Recipients: The Role of the Dermatologist in Management and Prevention: Part II.
Journal of the American Academy of Dermatology·2026
HPV-Associated Cutaneous Malignancies in Solid Organ Transplant Recipients: Identification and the Role of the Dermatologist: Part 1.
Journal of the American Academy of Dermatology·2026
RANDOMIZED CONTROLLED STUDY OF NEMOLIZUMAB IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND ASSOCIATED PRURITUS: NIKAIA-1.
Journal of the American Academy of Dermatology·2026
Guidelines for diagnostic testing in adults with presumed atopic dermatitis refractory to treatment.
Journal of the American Academy of Dermatology·2026
Multi-Omics Genome-Wide to Explore the Formation and Development Targets for Intracranial Aneurysms.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Regulatory and Quality Considerations of Antibody-drug Conjugates.
AAPS PharmSciTech·2026
HDAC inhibition via suberoylanilide hydroxamic acid ameliorates doxorubicin-induced cardiotoxicity.
Nature communications·2026